Alpa LaboratoriesNSE:ALPA -0.54%74 Days Payable is 87.19 as of Mar. 2026, which is 3% below its 10-year median of 90.29. GuruFocus rates NSE:ALPA with a GF Score™ of 74/100 and a GF Value™ of ₹92.83 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, Alpa Laboratories ranks better than 54.23% on this metric.
The historical rank and industry rank for Alpa Laboratories's Days Payable or its related term are showing as below:
NSE:ALPA'
s Days Payable Range Over the Past 10 Years
Min: 65.64 Med: 90.29 Max: 150.16
Current: 98.51
During the past 13 years, Alpa Laboratories's highest Days Payable was 150.16. The lowest was 65.64. And the median was 90.29.
NSE:ALPA's Days Payable is ranked better than 54.23% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs NSE:ALPA: 98.51
Alpa Laboratories's Days Payable
increased
from Mar. 2025 (58.49) to Mar. 2026 (87.19).
It may suggest that Alpa Laboratoriesdelayed paying its suppliers.
Alpa Laboratories Days Payable Related Terms
Alpa Laboratories Days Payable Historical Data
* Premium members only.
The historical data trend for Alpa Laboratories's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpa Laboratories Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Alpa Laboratories's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Alpa Laboratories's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpa Laboratories (NSE:ALPA) has a Days Payable of 87.19 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alpa Laboratories and its competitors. This is near median its historical median of 90.29. Over the past decade, Alpa Laboratories' Days Payable has ranged from 65.64 to 150.16. According to the industry distribution chart, Alpa Laboratories ranks #422 out of 922 companies in the Drug Manufacturers industry, placing it in the top 45.8%.
Is Alpa Laboratories' Days Payable too high?
Alpa Laboratories' current Days Payable of 87.19 is near median its 10-year median of 90.29. Over the past 10 years, this metric has ranged from a low of 65.64 to a high of 150.16. The Drug Manufacturers industry median Days Payable is 90.84. Alpa Laboratories' value of 87.19 is 4% below this industry median. Based on the distribution chart, Alpa Laboratories ranks #422 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Alpa Laboratories has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Alpa Laboratories ranks #422 out of 922 companies for Days Payable. This puts Alpa Laboratories in the upper half of its industry. The industry median Days Payable is 90.84. Alpa Laboratories' value of 87.19 is 4% below this benchmark. Historically, Alpa Laboratories' own Days Payable has ranged from 65.64 to 150.16 over the past decade. While the company's 10-year median is 90.29 vs. the industry median of 90.84, Alpa Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpa Laboratories's current Days Payable of 87.19 is 4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alpa Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpa Laboratories's current Days Payable is 87.19, which is near median its own 10-year median of 90.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹92.83, compared to a current price of ₹68.72 — trading 26% below its estimated fair value. The current Days Payable is 87.19, which is near median its 10-year median of 90.29 and 4% below the Drug Manufacturers industry median of 90.84. Alpa Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Days Payable is 87.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?
Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued.
The current stock price of ₹68.72 is trading 26% below its estimated GF Value™ of ₹92.83.
GuruFocus considers Alpa Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:ALPA:
Days Payable: 87.19 (near median its 10-year median of 90.29)
GF Value™: ₹92.83 vs. price of ₹68.72 (26% below fair value)
Industry Position: 4% below the Drug Manufacturers median (#422 of 922)
No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
74GF Score
Get the complete analysis for NSE:ALPA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ALPA has been successfully added to your 
